Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Management of hyperglycemia in type 2 diabetes: evidence and uncertainty.

Esposito K, Gentile S, Candido R, De Micheli A, Gallo M, Medea G, Ceriello A; Associazione Medici Diabetologi..

Cardiovasc Diabetol. 2013 May 30;12:81. doi: 10.1186/1475-2840-12-81.

2.

Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus.

Blonde L.

Am J Med. 2010 Mar;123(3 Suppl):S12-8. doi: 10.1016/j.amjmed.2009.12.005. Review.

PMID:
20206727
3.

Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes?

Esposito K, Ceriello A, Giugliano D.

Endocrine. 2013 Oct;44(2):343-5. doi: 10.1007/s12020-013-9918-x.

PMID:
23479044
4.

Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.

Dailey G.

Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025. Review.

PMID:
21704233
5.

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.

Shogbon AO, Levy SB.

Am J Health Syst Pharm. 2010 May 15;67(10):798-805. doi: 10.2146/ajhp090211. Review.

PMID:
20479101
6.

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.

Tschöpe D, Hanefeld M, Meier JJ, Gitt AK, Halle M, Bramlage P, Schumm-Draeger PM.

Cardiovasc Diabetol. 2013 Apr 10;12:62. doi: 10.1186/1475-2840-12-62. Review.

7.

Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.

Avilés-Santa L, Salinas K, Adams-Huet B, Raskin P.

J Investig Med. 2006 Jan;54(1):20-31.

PMID:
16409887
8.

Type II diabetes mellitus.

Edelman SV.

Adv Intern Med. 1998;43:449-500. Review.

PMID:
9506190
9.

Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia.

Haak T.

Adv Ther. 2012 Dec;29(12):1005-15. doi: 10.1007/s12325-012-0066-0. Review.

PMID:
23212658
10.
11.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
12.

Managing diabetes in patients with diabetes of long duration.

Triplitt CL.

Diabetes Educ. 2012 Jul-Aug;38(4 Suppl):23S-30S; quiz 31S. doi: 10.1177/0145721712449390. Review.

PMID:
22661393
13.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
14.

Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline.

Slinin Y, Ishani A, Rector T, Fitzgerald P, MacDonald R, Tacklind J, Rutks I, Wilt TJ.

Am J Kidney Dis. 2012 Nov;60(5):747-69. doi: 10.1053/j.ajkd.2012.07.017. Review.

PMID:
22999165
15.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
16.

[Cardiovascular risk reduction in the management of diabetic patients: what has changed since the '90s in the clinical approach?].

Consoli A, Di Fulvio P.

G Ital Cardiol (Rome). 2014 Dec;15(12 Suppl 2):21S-26S. doi: 10.1714/1762.19114. Italian.

PMID:
25623547
17.

[Should the occurrence of a first coronary event change the management of diabetes?].

Timsit J, Dubois-Laforgue D.

Arch Mal Coeur Vaiss. 2000 Dec;93 Spec No 4:39-44. Review. French.

PMID:
11296461
18.
19.

Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.

Vinik AI, Cincotta AH, Scranton RE, Bohannon N, Ezrokhi M, Gaziano JM.

Endocr Pract. 2012 Nov-Dec;18(6):931-43. doi: 10.4158/EP12187.OR. Erratum in: Endocr Pract. 2013 Jan-Feb;19(1):179.

PMID:
23186965
20.

[Antihyperglycemic Treatment Guidelines for diabetes mellitus type 2].

Clodi M, Abrahamian HE, Drexel H, Fasching P, Hoppichler F, Kautzky-Willer A, Lechleitner M, Ludvik B, Prager R, Roden M, Saely C, Schernthaner G, Schober E, Toplak H, Wascher T, Weitgasser R.

Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:10-6. doi: 10.1007/s00508-012-0263-5. German.

PMID:
23262748
Items per page

Supplemental Content

Support Center